Clinical Trials

Bladder Cancer Trials

Urinary BladderA Phase II Study of Consolidative Local Therapy in Patients With Locally Advanced or Oligo-metastatic Urothelial Carcinoma (la/mUC) Following Treatment Response to Systemic Therapy With or Without Metastasis-directed RadiotherapyPrincipal Investigator: Fed Ghali
Urinary BladderA Phase 2, Randomized, Multi-center, Open Label Trial to Evaluate the Safety and Efficacy of Intravesical Nadofaragene Firadenovec Alone or in Combination with Chemotherapy or Immunotherapy in Participants with High-grade Bacillus Calmette-Guerin Therapy (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)Principal Investigator: Fed Ghali

Prostate Cancer Trials

ProstatePRISM: Patient Experiences with PET Imaging in Prostate Cancer
ProstateSIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate CancerPrincipal Investigator: Isaac Y. Kim
Other Male Genital, ProstateCustomized Ablation of the Prostate With the TULSA Procedure Against Radical Prostatectomy Treatment: a Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN)Principal Investigator: Sandeep Arora
ProstateMR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer ResearchPrincipal Investigator: Preston C. Sprenkle

Kidney Cancer Trials

KidneyPhase II Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell CarcinomaPrincipal Investigator: Kimberly L. Johung

Kidney & Urinary Tract Trials

Diseases of the Kidney & Urinary TractTreating Kidney Disease in Patients with APOL1

All Urology Trials

Urinary BladderA Phase II Study of Consolidative Local Therapy in Patients With Locally Advanced or Oligo-metastatic Urothelial Carcinoma (la/mUC) Following Treatment Response to Systemic Therapy With or Without Metastasis-directed RadiotherapyPrincipal Investigator: Fed Ghali
Urinary BladderA Phase 2, Randomized, Multi-center, Open Label Trial to Evaluate the Safety and Efficacy of Intravesical Nadofaragene Firadenovec Alone or in Combination with Chemotherapy or Immunotherapy in Participants with High-grade Bacillus Calmette-Guerin Therapy (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)Principal Investigator: Fed Ghali
ProstatePRISM: Patient Experiences with PET Imaging in Prostate Cancer
ProstateOptimization of Prostate Biopsy - Micro-Ultrasound Versus MRI: A 3-arm Randomized Controlled Trial Evaluating the Role of 29MHz Micro-ultrasound in Guiding Prostate Biopsy in Men With Clinical Suspicion of Prostate Cancer.Principal Investigator: Joseph Renzulli
Not accepting volunteers
ProstateRandomized Three-Arm Trial to Evaluate the Effect of Neoadjuvant Apalutamide Alone or in Combination With Abiraterone Acetate and GnRH Agonist on Enhancing Surgical Outcome of Nerve-Sparing Radical Prostatectomy in Men With High-Risk Prostate CancerPrincipal Investigator: Isaac Y. Kim
Not accepting volunteers